Sign in
4

Changes in Ownership

Aptevo Therapeutics Inc. Filed Acc 0000950170-25-032187

President and CEO acquired 14 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
White Marvin L President and CEO 2025-03-02 Option exercise +8 49 D
White Marvin L President and CEO 2025-03-03 Option exercise +6 55 D
Derivatives
White Marvin L President and CEO 2025-03-02 Option exercise · Restricted Stock Unit −8 8 D
White Marvin L President and CEO 2025-03-03 Option exercise · Restricted Stock Unit −6 0 D
Loading xslF345X05/ownership.xml…